The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC

Author(s):
Voorneveld, P.W.; Kodach, L.L.; Jacobs, R.J.; Noesel, C.J.M. van; Peppelenbosch, M.P.; Korkmaz, K.S.; Molendijk, I.; Dekker, E.; Morreau, H.; Pelt, G.W. van; Tollenaar, R.A.E.M. (0000-0002-6831-6082); Mesker, W.; Hawinkels, L.J.A.C.; Paauwe, M.; Verspaget, H.W. (0000-0001-5769-6887); Geraets, D.T.; Hommes, D.W.; Offerhaus, G.J.A.; Brink, G.R. van den; Dijke, P. ten (0000-0002-2875-4723); Hardwick, J.C.H. (0000-0002-9575-5099)
Published
2015
Publication type
Article / Letter to editor
p53ALK3 inhibitor5-FUbeta-cateninmetastasischemotherapyinvasive frontcolon cancer
Date issued
2015-01-06
Language
English
Is part of
British Journal of Cancer (2015), Vol. 112, no. 1, p. 122-130
hdl
1887/117539
doi
10.1038/bjc.2014.560